Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
Gregory Y.H. Lip(Medical University of Białystok), Maria Bartlett, Changsheng Ma(Second Hospital of Shandong University), E. Badings, Subhash Banerjee(Baylor University Medical Center), Paul J.A.M. Brouwers(Medisch Spectrum Twente), Antonio Baldi, Agnieszka Kotalczyk(Medical University of Silesia), Sabrina Marler(Boehringer Ingelheim (United States)), Christine Teutsch(Boehringer Ingelheim (Germany)), Nicolas Breton, Kevin D. Browne(Philadelphia VA Medical Center), Claude Brunschwig, A. Bruni, John Bullinga, Ermentina Bagni, Pedro Adragão(Hospital de Santa Cruz), Seth Baker, Sergio Agosti, Dzifa Wosornu Abban, Aurélie Buhl, Srinivas Addala, Luciano Marcelo Backes, Sérgio Dubner, Richard Bala, Gonzalo Barón‐Esquivias(San Raffaele University of Rome), Marica Bracic Kalan, Kenneth J. Rothman(Boston University), Piergiuseppe Agostoni(University of Milan), Walter Ageno(University of Padua), Venkatesh Kumar Gurusamy(Boehringer Ingelheim (Germany)), Jordi Bruguera Cortada, Francisco Aguilar(Jefferson Einstein Philadelphia Hospital), Alan J. Bank(United Heart and Vascular Clinic), Jonathan L. Halperin(Icahn School of Medicine at Mount Sinai), Hervé Buathier, Drew Bradman, Rajesh Aggarwal(Southend University Hospital NHS Foundation Trust), Emad F. Aziz(Mount Sinai Hospital), Menno V. Huisman(Leiden University Medical Center), Luis Aguinaga(Centro Científico Tecnológico - Tucumán), Shigenobu Bando(Tottori Prefectural Kousei Hospital), Nasser Abdul, D. H. Brautigam, Atilio Marcelo Abud, Hans-Christoph Diener(Good Samaritan Hospital), Julio Aguilar Linares, Craig Barr(Russells Hall Hospital), Fran Adams
Cited by 0
Related Papers
Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
|New England Journal of Medicine|2011|9.4k
Guidelines on the management of valvular heart disease (version 2012)
|European Heart Journal|2012|3.6k
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
|European Heart Journal|2017|3k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k